Humira and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data
Summary:
Common peroneal nerve dysfunction is reported as a side effect among people who take Humira (adalimumab), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Methotrexate, and have Psoriatic arthropathy.
The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Humira. It is created by eHealthMe based on reports of 758,421 people who have side effects when taking Humira from the FDA, and is updated regularly.
What is Humira?
Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.
What is Common peroneal nerve dysfunction?
Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,129 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.
758,421 people reported to have side effects when taking Humira.
Among them, 195 people (0.03%) have Common peroneal nerve dysfunction.
Among these 195 people:
How long have people been on Humira when they have Common peroneal nerve dysfunction? *
What is the gender of people who have Common peroneal nerve dysfunction when taking Humira? *
What is the age of people who have Common peroneal nerve dysfunction when taking Humira? *
What are other drugs people take besides Humira? *
What are other side effects people have besides Common peroneal nerve dysfunction? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Humira and have Common peroneal nerve dysfunction?
- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Humira:
- Humira (761,396 reports)
Common peroneal nerve dysfunction treatments and more:
- Common peroneal nerve dysfunction (7,841 reports)
How severe was Common peroneal nerve dysfunction and when was it recovered:
Expand to all the drugs that have ingredients of adalimumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Humira:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Common peroneal nerve dysfunction:
- Common peroneal nerve dysfunction (651 drugs)
Browse all the conditions that are associated with Common peroneal nerve dysfunction:
- Common peroneal nerve dysfunction (1,129 conditions)
Related publications that referenced our studies
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Keytruda cause Protein Total Decreased? - 2 seconds ago
- Drug interactions of Selenium and Bortezomib - 5 seconds ago
- Drug interactions of Lomotil and Adalat - 7 seconds ago
- Drug interactions of Diltiazem Hydrochloride and Calcium - 9 seconds ago
- Drug interactions of Iodine and Latanoprost - 9 seconds ago
- Could Voltaren Arthritis Pain cause Haematochezia? - 13 seconds ago
- Drug interactions of Dipyridamole and Paroxetine - 13 seconds ago
- Could Captopril cause Impaired Healing? - 15 seconds ago
- Drug interactions of Spectracef and Yasmin - 16 seconds ago
- Drug interactions of Diphen and Olanzapine - 18 seconds ago